Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

While charitable dollars have flowed in to plug some gaps, “philanthropy cannot replace federal funding,” said Dustin Sposato ...

A new study from the Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Democrats in the U.S. Senate slammed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for cutting biomedical research and public health programs at the committee hearing.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

A new study from Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with long COVID. Researchers found that nearly 40% of pediatric patients with long ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.